Ignet
Search (e.g., vaccine, IFNG): Help
About
Home
Introduction
Statistics
Programs
Dignet
Gene
GenePair
BioSummarAI
Help & Docs
Documents
Help
FAQs
Links
Acknowledge
Disclaimer
Contact Us
UM Logo

UMMS Logo

UMMS Logo

Gene Information

Gene symbol: MYOCD

Gene name: myocardin

HGNC ID: 16067

Synonyms: MYCD

Related Genes

# Gene Symbol Number of hits
1 MYH11 1 hits
2 SMN1 1 hits
3 SMTN 1 hits
4 SRF 1 hits
5 TGFA 1 hits

Related Sentences

# PMID Sentence
1 21950552 Reduced expression of myocardin and serum response factor in the cavernous tissue of diabetic rats.
2 21950552 This study aimed to investigate the expression of myocardin and serum response factor (SRF) in the cavernous tissue of diabetic rats.
3 21950552 Western blot and qRT-PCR were used to determine the protein and mRNA expression levels of myocardin and SRF.
4 21950552 The mRNA and protein expression levels of myocardin and SRF were reduced in the cavernous tissue of diabetic rats compared with the control group (P < 0.001).
5 21950552 It is concluded that diabetes inhibits the mRNA and protein expression of both myocardin and SRF in the cavernous tissue.
6 21950552 Reduced expression of myocardin and serum response factor in the cavernous tissue of diabetic rats.
7 21950552 This study aimed to investigate the expression of myocardin and serum response factor (SRF) in the cavernous tissue of diabetic rats.
8 21950552 Western blot and qRT-PCR were used to determine the protein and mRNA expression levels of myocardin and SRF.
9 21950552 The mRNA and protein expression levels of myocardin and SRF were reduced in the cavernous tissue of diabetic rats compared with the control group (P < 0.001).
10 21950552 It is concluded that diabetes inhibits the mRNA and protein expression of both myocardin and SRF in the cavernous tissue.
11 21950552 Reduced expression of myocardin and serum response factor in the cavernous tissue of diabetic rats.
12 21950552 This study aimed to investigate the expression of myocardin and serum response factor (SRF) in the cavernous tissue of diabetic rats.
13 21950552 Western blot and qRT-PCR were used to determine the protein and mRNA expression levels of myocardin and SRF.
14 21950552 The mRNA and protein expression levels of myocardin and SRF were reduced in the cavernous tissue of diabetic rats compared with the control group (P < 0.001).
15 21950552 It is concluded that diabetes inhibits the mRNA and protein expression of both myocardin and SRF in the cavernous tissue.
16 21950552 Reduced expression of myocardin and serum response factor in the cavernous tissue of diabetic rats.
17 21950552 This study aimed to investigate the expression of myocardin and serum response factor (SRF) in the cavernous tissue of diabetic rats.
18 21950552 Western blot and qRT-PCR were used to determine the protein and mRNA expression levels of myocardin and SRF.
19 21950552 The mRNA and protein expression levels of myocardin and SRF were reduced in the cavernous tissue of diabetic rats compared with the control group (P < 0.001).
20 21950552 It is concluded that diabetes inhibits the mRNA and protein expression of both myocardin and SRF in the cavernous tissue.
21 21950552 Reduced expression of myocardin and serum response factor in the cavernous tissue of diabetic rats.
22 21950552 This study aimed to investigate the expression of myocardin and serum response factor (SRF) in the cavernous tissue of diabetic rats.
23 21950552 Western blot and qRT-PCR were used to determine the protein and mRNA expression levels of myocardin and SRF.
24 21950552 The mRNA and protein expression levels of myocardin and SRF were reduced in the cavernous tissue of diabetic rats compared with the control group (P < 0.001).
25 21950552 It is concluded that diabetes inhibits the mRNA and protein expression of both myocardin and SRF in the cavernous tissue.
26 22592762 The cavernous tissue segments were subjected to quantitative real-time polymerase chain reaction to determine the expressions of smooth muscle α-actin (SMA), SM myosin heavy chain (SMMHC), smoothelin, calponin and myocardin.
27 22592762 Cell contractility in vitro and western blot analysis of SMA and SMMHC in the cavernous tissues and cells were determined.
28 22592762 Compared with the control group (n=8) and the diabetes mellitus group (n=5), the expressions of SMA, calponin, SMMHC, smoothelin and myocardin mRNA were decreased in the cavernous tissues in rats of the diabetic erectile dysfunction group (n=15; P=0.001 and 0.02, P=0.014 and 0.012, both P<0.001, P=0.005 and <0.001, P=0.003 and 0.035, respectively).
29 22592762 The levels of SMA and SMMHC proteins showed a significant decrease in cavernous tissues and cultured cells in rats of the diabetic erectile dysfunction group.
30 23178076 SMA expression is regulated by transforming growth factor (TGF)-β1 and cell contact disruption, through signaling events targeting the serum response factor-myocardin-related transcription factor (MRTF) complex.
31 23178076 When co-expressed, it inhibited the stimulatory effects of MRTF-A, MRTF-B or the constitutive active forms of RhoA, Rac1, or Cdc42 on the SMA promoter.